Clinical Equivalence Study of Mometasone Nasal Spray, 50 Mcg/Actuation

Clinical trial NCT01523236 · COMPLETED

Trial details

NCT number: NCT01523236
Sponsor: Teva Pharmaceuticals USA
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Seasonal Allergic Rhinitis

Start date: 2011-12-01
Primary completion: 2012-01-01
Enrollment: 800

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.